New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Hy BioPharma Inc.
www.hybiopharma.com
Latest From Hy BioPharma Inc.
Hy BioPharma Inc.
Hy BioPharma is developing hypericin phototherapeutics for cancers and autoimmune disorders. The Israeli/US start-up is also in Phase I/IIb trials for an oral formulation of hypericin for possible use in combination therapy with Temodar for the treatment of glioblastoma.
Start-Up Previews (07/2008)
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Glioblastoma Start-Ups Get Specific," "Glaucoma Start-Ups Reach Critical Mass," and "ALS on the Cusp." Plus these Start-Ups Across Health Care: EarlySense, NeoChord, and Pantec Biosolutions.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Immune Disorders
- Inflammation
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Hy BioPharma Inc.
- Senior Management
-
Michael Steinberg, CEO
Zadik Hazan, MD, VP, Res. - Contact Info
-
Hy BioPharma Inc.
Phone: (215) 918-3336
2500 York Rd.
Ste. 100
Jamison, PA 18929
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hy BioPharma Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice